HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Development, characterisation and pharmacoscintigraphic evaluation of nano-fluticasone propionate dry powder inhalation as potential antidote against inhaled toxic gases.

Abstract
Acute lung injuries caused due to inhalation of toxic irritant gases such as ammonia, chlorine, hot smoke and burning plastic fumes predominantly affect the airways, causing tracheitis, bronchitis, and other inflammatory responses. The purpose was to develop and characterise nanoparticle based fluticasone propionate (FP) DPI formulation and assess its in vitro and in vivo pulmonary deposition using pharmacoscintigraphy. FP nanoparticles were prepared by nanoprecipitation method. Optimisation was carried out with the help of Box-Behnken statistical design. Nanoparticles were characterised with the help of SEM, FT-IR, DSC and XRD. Anderson cascade impaction showed that nano-FP exhibited significantly higher respirable fraction of 60.3 ± 2.41 as compared to 16.4 ± 0.66 for micronised form. Ventilation lung scintigraphy in human volunteers confirmed significant increase in drug delivery till alveolar region with nano-FP in comparison to micronised drug. Results indicate that the developed formulation may have a potential prophylactic/therapeutic role against toxic, irritant gas inhalation.
AuthorsRaisuddin Ali, Gaurav Mittal, Rashid Ali, Manish Kumar, Roop Kishan Khar, Farhan Jalees Ahmad, Aseem Bhatnagar
JournalJournal of microencapsulation (J Microencapsul) Vol. 30 Issue 6 Pg. 546-58 ( 2013) ISSN: 1464-5246 [Electronic] England
PMID23379507 (Publication Type: Journal Article)
Chemical References
  • Androstadienes
  • Anti-Inflammatory Agents
  • Antidotes
  • Fluticasone
Topics
  • Administration, Inhalation
  • Androstadienes (administration & dosage, pharmacokinetics)
  • Anti-Inflammatory Agents (administration & dosage, pharmacokinetics)
  • Antidotes (administration & dosage, pharmacokinetics)
  • Fluticasone
  • Humans
  • Lung (diagnostic imaging, metabolism)
  • Nanoparticles (chemistry, ultrastructure)
  • Particle Size
  • Radionuclide Imaging

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: